US Stock MarketDetailed Quotes

BRNS Barinthus Biotherapeutics

Watchlist
  • 0.990
  • -0.020-1.98%
Close Mar 21 16:00 ET
  • 0.990
  • 0.0000.00%
Post 16:05 ET
39.94MMarket Cap-0.64P/E (TTM)

Barinthus Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
43.17%-28.94M
166.76%13.09M
-62.61%-18.2M
29.20%-12.01M
-272.46%-11.82M
-252.89%-50.93M
-72.82%-19.6M
-194.17%-11.19M
-102.04%-16.96M
51.76%-3.17M
Net income from continuing operations
16.70%-61.18M
-19.09%-20.59M
42.39%-8.13M
28.88%-16.94M
14.83%-15.52M
-1,480.32%-73.45M
18.30%-17.29M
-271.63%-14.11M
-251.85%-23.82M
-807.96%-18.22M
Operating gains losses
-108.62%-649K
-140.15%-2.67M
141.73%2.61M
-87.76%443K
-129.28%-1.03M
129.82%7.53M
-43.01%6.65M
65.69%-6.24M
--3.62M
--3.5M
Depreciation and amortization
6.83%5.8M
-0.49%1.43M
0.07%1.48M
12.93%1.47M
17.12%1.43M
25.58%5.43M
21.92%1.44M
24.07%1.47M
30.95%1.3M
26.40%1.22M
Deferred tax
98.57%-44K
100.37%3K
99.50%-3K
99.38%-7K
92.83%-37K
29.10%-3.08M
57.55%-821K
3.68%-602K
-24.15%-1.14M
40.21%-516K
Other non cash items
67.04%2.36M
198.07%1.54M
108.33%2K
-30.87%383K
18.41%431K
21.43%1.41M
191.18%517K
-104.17%-24K
-28.15%554K
-4.96%364K
Change In working capital
-57.85%2.6M
239.24%15.15M
-285.20%-15.29M
168.63%1.46M
-84.43%1.29M
211.71%6.17M
-323.42%-10.88M
-57.91%8.26M
106.06%542K
160.59%8.25M
-Change in receivables
-141.34%-2.35M
2,424.95%12.86M
-1,510.14%-15.55M
429.46%683K
-104.69%-331K
221.35%5.67M
-270.68%-553K
-108.30%-966K
-68.69%129K
141.42%7.06M
-Change in prepaid assets
65.59%3.64M
151.16%1.56M
-14.99%1.82M
-64.09%-1.61M
-54.16%1.88M
201.38%2.2M
-491.40%-3.05M
-30.25%2.14M
79.93%-983K
464.85%4.09M
-Change in payables and accrued expense
197.76%1.35M
121.66%1.52M
-131.23%-2.28M
150.11%3.45M
55.43%-1.35M
-173.24%-1.39M
-112.12%-7.04M
48.21%7.29M
132.26%1.38M
-166.14%-3.02M
-Change in other current assets
--0
--0
--0
--0
--0
133.07%128K
193.06%201K
---211K
108.98%15K
3,175.00%123K
-Change in other current liabilities
-302.02%-1.79M
-8.54%-483K
---487K
---473K
---346K
---445K
---445K
--0
--0
--0
-Change in other working capital
--1.74M
---306K
--1.21M
---595K
--1.43M
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
43.17%-28.94M
166.76%13.09M
-62.61%-18.2M
29.20%-12.01M
-272.46%-11.82M
-252.89%-50.93M
-72.82%-19.6M
-194.17%-11.19M
-102.04%-16.96M
51.76%-3.17M
Investing cash flow
Cash flow from continuing investing activities
83.52%-892K
-281.70%-278K
-216.67%-114K
93.65%-192K
87.71%-308K
5.86%-5.41M
126.11%153K
98.22%-36K
-47.18%-3.02M
-129.58%-2.51M
Net PPE purchase and sale
83.52%-892K
-281.70%-278K
-216.67%-114K
93.65%-192K
87.71%-308K
5.86%-5.41M
126.11%153K
98.22%-36K
-47.18%-3.02M
-129.58%-2.51M
Cash from discontinued investing activities
Investing cash flow
83.52%-892K
-281.70%-278K
-216.67%-114K
93.65%-192K
87.71%-308K
5.86%-5.41M
126.11%153K
98.22%-36K
-47.18%-3.02M
-129.58%-2.51M
Financing cash flow
Cash flow from continuing financing activities
15.54%2.16M
667.89%837K
910.87%465K
1,178.57%358K
-70.22%503K
476.00%1.87M
-77.48%109K
46K
28K
1,162.26%1.69M
Net common stock issuance
6.29%2.16M
667.89%837K
910.87%465K
293.41%358K
-71.88%503K
320.45%2.04M
-77.48%109K
--46K
--91K
--1.79M
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Net other financing activities
----
----
----
----
----
---163K
--0
--0
---63K
---100K
Cash from discontinued financing activities
Financing cash flow
15.54%2.16M
667.89%837K
910.87%465K
1,178.57%358K
-70.22%503K
476.00%1.87M
-77.48%109K
--46K
--28K
1,162.26%1.69M
Net cash flow
Beginning cash position
-26.90%142.09M
-33.81%106.1M
-31.93%117.77M
-32.07%129.97M
-26.90%142.09M
-9.19%194.39M
-19.89%160.31M
-10.03%173.03M
-4.62%191.33M
-9.19%194.39M
Current changes in cash
49.20%-27.67M
170.55%13.65M
-59.62%-17.85M
40.66%-11.84M
-191.26%-11.63M
-174.30%-54.47M
-68.99%-19.34M
-213.33%-11.18M
-90.98%-19.95M
49.02%-3.99M
Effect of exchange rate changes
-193.09%-2.02M
-754.81%-7.35M
500.97%6.18M
-121.58%-357K
-152.62%-492K
1,060.96%2.17M
-80.41%1.12M
26.28%-1.54M
-24.06%1.65M
116.61%935K
End cash Position
-20.90%112.4M
-20.90%112.4M
-33.81%106.1M
-31.93%117.77M
-32.07%129.97M
-26.90%142.09M
-26.90%142.09M
-19.89%160.31M
-10.03%173.03M
-4.62%191.33M
Free cash flow
47.05%-29.83M
165.85%12.81M
-63.11%-18.31M
38.95%-12.2M
-113.52%-12.13M
-173.90%-56.34M
-63.05%-19.45M
-218.45%-11.23M
-91.25%-19.98M
25.94%-5.68M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 43.17%-28.94M166.76%13.09M-62.61%-18.2M29.20%-12.01M-272.46%-11.82M-252.89%-50.93M-72.82%-19.6M-194.17%-11.19M-102.04%-16.96M51.76%-3.17M
Net income from continuing operations 16.70%-61.18M-19.09%-20.59M42.39%-8.13M28.88%-16.94M14.83%-15.52M-1,480.32%-73.45M18.30%-17.29M-271.63%-14.11M-251.85%-23.82M-807.96%-18.22M
Operating gains losses -108.62%-649K-140.15%-2.67M141.73%2.61M-87.76%443K-129.28%-1.03M129.82%7.53M-43.01%6.65M65.69%-6.24M--3.62M--3.5M
Depreciation and amortization 6.83%5.8M-0.49%1.43M0.07%1.48M12.93%1.47M17.12%1.43M25.58%5.43M21.92%1.44M24.07%1.47M30.95%1.3M26.40%1.22M
Deferred tax 98.57%-44K100.37%3K99.50%-3K99.38%-7K92.83%-37K29.10%-3.08M57.55%-821K3.68%-602K-24.15%-1.14M40.21%-516K
Other non cash items 67.04%2.36M198.07%1.54M108.33%2K-30.87%383K18.41%431K21.43%1.41M191.18%517K-104.17%-24K-28.15%554K-4.96%364K
Change In working capital -57.85%2.6M239.24%15.15M-285.20%-15.29M168.63%1.46M-84.43%1.29M211.71%6.17M-323.42%-10.88M-57.91%8.26M106.06%542K160.59%8.25M
-Change in receivables -141.34%-2.35M2,424.95%12.86M-1,510.14%-15.55M429.46%683K-104.69%-331K221.35%5.67M-270.68%-553K-108.30%-966K-68.69%129K141.42%7.06M
-Change in prepaid assets 65.59%3.64M151.16%1.56M-14.99%1.82M-64.09%-1.61M-54.16%1.88M201.38%2.2M-491.40%-3.05M-30.25%2.14M79.93%-983K464.85%4.09M
-Change in payables and accrued expense 197.76%1.35M121.66%1.52M-131.23%-2.28M150.11%3.45M55.43%-1.35M-173.24%-1.39M-112.12%-7.04M48.21%7.29M132.26%1.38M-166.14%-3.02M
-Change in other current assets --0--0--0--0--0133.07%128K193.06%201K---211K108.98%15K3,175.00%123K
-Change in other current liabilities -302.02%-1.79M-8.54%-483K---487K---473K---346K---445K---445K--0--0--0
-Change in other working capital --1.74M---306K--1.21M---595K--1.43M--------------------
Cash from discontinued investing activities
Operating cash flow 43.17%-28.94M166.76%13.09M-62.61%-18.2M29.20%-12.01M-272.46%-11.82M-252.89%-50.93M-72.82%-19.6M-194.17%-11.19M-102.04%-16.96M51.76%-3.17M
Investing cash flow
Cash flow from continuing investing activities 83.52%-892K-281.70%-278K-216.67%-114K93.65%-192K87.71%-308K5.86%-5.41M126.11%153K98.22%-36K-47.18%-3.02M-129.58%-2.51M
Net PPE purchase and sale 83.52%-892K-281.70%-278K-216.67%-114K93.65%-192K87.71%-308K5.86%-5.41M126.11%153K98.22%-36K-47.18%-3.02M-129.58%-2.51M
Cash from discontinued investing activities
Investing cash flow 83.52%-892K-281.70%-278K-216.67%-114K93.65%-192K87.71%-308K5.86%-5.41M126.11%153K98.22%-36K-47.18%-3.02M-129.58%-2.51M
Financing cash flow
Cash flow from continuing financing activities 15.54%2.16M667.89%837K910.87%465K1,178.57%358K-70.22%503K476.00%1.87M-77.48%109K46K28K1,162.26%1.69M
Net common stock issuance 6.29%2.16M667.89%837K910.87%465K293.41%358K-71.88%503K320.45%2.04M-77.48%109K--46K--91K--1.79M
Proceeds from stock option exercised by employees --0--0--0--0--0--0--0--0--0--0
Net other financing activities -----------------------163K--0--0---63K---100K
Cash from discontinued financing activities
Financing cash flow 15.54%2.16M667.89%837K910.87%465K1,178.57%358K-70.22%503K476.00%1.87M-77.48%109K--46K--28K1,162.26%1.69M
Net cash flow
Beginning cash position -26.90%142.09M-33.81%106.1M-31.93%117.77M-32.07%129.97M-26.90%142.09M-9.19%194.39M-19.89%160.31M-10.03%173.03M-4.62%191.33M-9.19%194.39M
Current changes in cash 49.20%-27.67M170.55%13.65M-59.62%-17.85M40.66%-11.84M-191.26%-11.63M-174.30%-54.47M-68.99%-19.34M-213.33%-11.18M-90.98%-19.95M49.02%-3.99M
Effect of exchange rate changes -193.09%-2.02M-754.81%-7.35M500.97%6.18M-121.58%-357K-152.62%-492K1,060.96%2.17M-80.41%1.12M26.28%-1.54M-24.06%1.65M116.61%935K
End cash Position -20.90%112.4M-20.90%112.4M-33.81%106.1M-31.93%117.77M-32.07%129.97M-26.90%142.09M-26.90%142.09M-19.89%160.31M-10.03%173.03M-4.62%191.33M
Free cash flow 47.05%-29.83M165.85%12.81M-63.11%-18.31M38.95%-12.2M-113.52%-12.13M-173.90%-56.34M-63.05%-19.45M-218.45%-11.23M-91.25%-19.98M25.94%-5.68M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
+14.85%
New Fortress Energy
NFE
+7.92%
Cars.com
CARS
+2.11%
Halozyme Therapeutics
HALO
+1.31%
Collegium Pharmaceutical
COLL
+0.40%

Unlock the Full List